 | • レポートコード：MRC2401A103 • 出版社/出版日：Transparency Market Research / 2023年11月 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 肺薬物送達装置市場-レポート範囲 TMRの調査レポート「世界の肺薬物送達装置市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の肺薬物送達装置市場の収益を提供しています。また、2023年から2031年までの世界の肺薬物送達装置市場の複合年間成長率（CAGR %）も掲載しています。 本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、肺薬物送達装置市場を理解しました。 二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の肺薬物送達装置市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは世界の肺薬物送達装置市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の肺薬物送達装置市場への参入に関心のある企業にとっても貴重なツールとなります。 本レポートでは、世界の肺薬物送達装置市場の競争状況について掘り下げています。世界の肺薬物送達装置市場で事業を展開する主要プレイヤーを特定し、各プレイヤーを様々な属性でプロファイルしています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の肺薬物送達装置市場におけるプレイヤーの属性です。 世界の肺薬物送達装置市場レポートで回答された主な質問 - 予測期間中の全地域における肺薬物送達装置の売上高/収益は？ - 世界の肺薬物送達装置市場におけるビジネスチャンスは？ - 市場の主な促進要因、阻害要因、機会、脅威は？ - 予測期間中に最も速いCAGRで拡大する地域市場は？ - 2031年に世界で最も高い収益を上げると予測されるセグメントは？ - 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？ - 世界市場で事業を展開する各企業の市場ポジションは？ 調査目的・調査アプローチ 世界の肺薬物送達装置市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、主要セグメントの過去と予測期間末の市場シェアの比較も可能です。 本レポートでは、世界の肺薬物送達装置市場を製品、エンドユーザー、地域の観点から分析。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界肺薬物送達装置市場への投資について十分な情報に基づいたビジネス上の意思決定を行うことができます。 |
1. エグゼクティブサマリー
2. 仮定・調査方法
3. エグゼクティブサマリー：世界の肺薬物送達装置市場
4. 市場概要
5. 主要インサイト
6. 世界の肺薬物送達装置市場分析・予測：製品種類別
7. 世界の肺薬物送達装置市場分析・予測：用途別
8. 世界の肺薬物送達装置市場分析・予測：流通チャネル別
9. 世界の肺薬物送達装置市場分析・予測：地域別
10. 北米の肺薬物送達装置市場分析・予測
11. ヨーロッパの肺薬物送達装置市場分析・予測
12. アジア太平洋の肺薬物送達装置市場分析・予測
13. 中南米の肺薬物送達装置市場分析・予測
14. 中東・アフリカの肺薬物送達装置市場分析・予測
15. 競争状況
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pulmonary Drug Delivery Devices Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. COVID-19 Pandemic Impact on Industry
6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Product Type, 2023-2031
6.3.1. Dry Powder Inhalers
6.3.2. Metered Dose Inhalers
6.3.3. Nebulizers
6.4. Market Attractiveness, by Product Type
7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value & Volume Forecast, by Application, 2023-2031
7.3.1. Asthma
7.3.2. COPD
7.3.3. Cystic Fibrosis
7.3.4. Others
7.4. Market Attractiveness, by Application
8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
8.3.1. Retail Pharmacies
8.3.2. Hospital Pharmacies
8.3.3. E-Commerce
8.4. Market Attractiveness, by Distribution Channel
9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2023-2031
10.2.1. Dry Powder Inhalers
10.2.2. Metered Dose Inhalers
10.2.3. Nebulizers
10.3. Market Attractiveness, by Product Type
10.4. Market Value & Volume Forecast, by Application, 2023-2031
10.4.1. Asthma
10.4.2. COPD
10.4.3. Cystic Fibrosis
10.4.4. Others
10.5. Market Attractiveness, by Application
10.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
10.6.1. Retail Pharmacies
10.6.2. Hospital Pharmacies
10.6.3. E-Commerce
10.7. Market Attractiveness, by Distribution Channel
10.8. Market Value & Volume Forecast, by Country, 2023-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Product Type
10.9.2. By Application
10.9.3. By Distribution Channel
10.9.4. By Country
11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2023-2031
11.2.1. Dry Powder Inhalers
11.2.2. Metered Dose Inhalers
11.2.3. Nebulizers
11.3. Market Attractiveness, by Product Type
11.4. Market Value & Volume Forecast, by Application, 2023-2031
11.4.1. Asthma
11.4.2. COPD
11.4.3. Cystic Fibrosis
11.4.4. Others
11.5. Market Attractiveness, by Application
11.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
11.6.1. Retail Pharmacies
11.6.2. Hospital Pharmacies
11.6.3. E-Commerce
11.7. Market Attractiveness, by Distribution Channel
11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Product Type
11.9.2. By Application
11.9.3. By Distribution Channel
11.9.4. By Country/Sub-region
12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2023-2031
12.2.1. Dry Powder Inhalers
12.2.2. Metered Dose Inhalers
12.2.3. Nebulizers
12.3. Market Attractiveness, by Product Type
12.4. Market Value & Volume Forecast, by Application, 2023-2031
12.4.1. Asthma
12.4.2. COPD
12.4.3. Cystic Fibrosis
12.4.4. Others
12.5. Market Attractiveness, by Application
12.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
12.6.1. Retail Pharmacies
12.6.2. Hospital Pharmacies
12.6.3. E-Commerce
12.7. Market Attractiveness, by Distribution Channel
12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Product Type
12.9.2. By Application
12.9.3. By Distribution Channel
12.9.4. By Country/Sub-region
13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2023-2031
13.2.1. Dry Powder Inhalers
13.2.2. Metered Dose Inhalers
13.2.3. Nebulizers
13.3. Market Attractiveness, by Product Type
13.4. Market Value & Volume Forecast, by Application, 2023-2031
13.4.1. Asthma
13.4.2. COPD
13.4.3. Cystic Fibrosis
13.4.4. Others
13.5. Market Attractiveness, by Application
13.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
13.6.1. Retail Pharmacies
13.6.2. Hospital Pharmacies
13.6.3. E-Commerce
13.7. Market Attractiveness, by Distribution Channel
13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Product Type
13.9.2. By Application
13.9.3. By Distribution Channel
13.9.4. By Country/Sub-region
14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2023-2031
14.2.1. Dry Powder Inhalers
14.2.2. Metered Dose Inhalers
14.2.3. Nebulizers
14.3. Market Attractiveness, by Product Type
14.4. Market Value & Volume Forecast, by Application, 2023-2031
14.4.1. Asthma
14.4.2. COPD
14.4.3. Cystic Fibrosis
14.4.4. Others
14.5. Market Attractiveness, by Application
14.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
14.6.1. Retail Pharmacies
14.6.2. Hospital Pharmacies
14.6.3. E-Commerce
14.7. Market Attractiveness, by Distribution Channel
14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Product Type
14.9.2. By Application
14.9.3. By Distribution Channel
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. AstraZeneca Plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Novartis AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Boehringer Ingelheim GmbH
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. GlaxoSmithKline Plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Merck & Co., Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
Table 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 02: Global Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 03: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 04: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 05: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2023-2031
Table 06: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2023-2031
Table 07: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 08: North America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 09: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 11: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 12: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 13: Europe Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 14: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 15: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
Table 16: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 17: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 18: Asia Pacific Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 19: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 20: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031
Table 21: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 22: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 23: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 24: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 25: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031
Table 26: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
Table 27: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031
Table 28: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031
Table 29: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031
Table 30: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031